Hundreds of millions of vaccine doses will require hundreds of millions of syringes from companies such as BD.

“Drug-delivery devices are really the foundation of our company, and we have a long history in supporting global immunization campaigns,” Elizabeth Woody, BD’s SVP of public affairs, explained to MassDevice‘s sister site Drug Delivery Business News. (Listen to the interview in our final DeviceTalks Weekly podcast of 2020 — out in the coming days.)
The stakes couldn’t be higher as global deaths from the coronavirus pandemic reach millions.
Go to DDBN and discover four insights from Woody on how BD is tackling the challenge.